Proven patient engagement solutions grounded in behavioural science

Improving experience and outcomes across the health journey

Designed to empower Change for Good

What we do

Atlantis Health helps pharma and healthcare organisations improve patient experience, outcomes and impact through proven patient engagement solutions grounded in behavioural science.

We design and deliver solutions from early insight and strategy to implementation, measurement and optimisation. Our work addresses a range of patient challenges across the health journey including:

  • disease awareness and activation
  • treatment access and initiation
  • medication adherence and persistence
  • self-management of wider health behaviors.

Every solution is shaped around what drives patient behaviour in each therapy area, treatment context and journey stage. We work closely with clients, patients and healthcare professionals to create engagement that is relevant, practical, compliant and effective in the real world.

How we do this

We apply behavioural science because engagement is shaped by addressing barriers, motivators and needs, not by information alone. By understanding and targeting what drives patient behaviour in each therapy area, treatment context and journey stage, we design more effective interventions and experiences.

We co-design solutions with patients, healthcare professionals and client teams to ensure they are meaningful for patients and workable in practice.

We deliver personalised engagement at scale by tailoring experiences to each individual’s behavioural drivers, needs and preferences through omnichannel and governed AI approaches that blend human and digital behavioral support - reaching them at the right time, with the right engagement for where they are in their journey.

Proven patient engagement solutions across the health journey

At each stage of their journey, people living with a long-term condition often face different challenges, needs and barriers that can have a negative impact on health behaviors and outcomes.

Our personalised, behaviourally-informed solutions understand and address the relevant and modifiable patient factors for a specific therapy area, treatment context and journey stage. 

Pre-diagnosis
Active

Discovery and pre-diagnosis activation

Helping patients and caregivers recognise symptoms needing medical advice, and motivating them to research, discover and adopt preventive health behaviours

Diagnosis
Accept

Diagnosis acceptance

Evidence-based tools and training to guide effective HCP-patient dialogue and shared healthcare decision-making around a new diagnosis, disease progression, or new treatment options

Treatment initiation
Access

Treatment initiation and access

Ensuring safe and smooth treatment initiation, through direct-to-patient services including medication delivery, reimbursement support and self-administered treatment training

Illness self-management
Empower

Illness self-management empowerment

Highly personalised, omnichannel and AI-enabled patient support and adherence programs designed to build patient skills, confidence and motivation to manage the practical and emotional impact of long-term conditions

For over 25 years, we've supported the world’s leading pharmaceutical and healthcare companies at the global and local level

We've partnered with like-minded clients to create personalized behavior change and engagement solutions that empower patients and HCPs managing long-term conditions in over 30 countries.

Abbvie
Bayer
GSK
Janssen
Lilly
Novartis
Nzblood
Roche
Sanofi
Takeda
UCB
Merck

News and publications

Our latest health psychology-based insights as well as published results of solutions we've designed to address specific health behaviour change challenges.

Press release: Global Patient Study Identifies Key Reasons Driving Nonadherence to Self-Administered Cancer Medications

Atlantis Health announces the key findings of the Global Oncology Patient N…

Evidence for Change: Effective Medication Adherence Strategies

Dr. Kate Perry summarises a research review looking at effective strategies…

Case Study: Integrated Patient Support for Psoriatic Disease

Overview of an integrated programme designed to support people with psoriat…

Evidence for Change: Driving Patient Engagement Impact and Adherence in Oncology

Dr Kate Perry, our Group Behavioural Science Director, discusses key findin…